Discovery of YK-029A, a novel mutant EGFR inhibitor targeting both T790 M and exon 20 insertion mutations, as a treatment for NSCLC
1. 系统已在2025-03-07 14:44:17对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.ejmech.2023.115590
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0223523423005561
其他信息:
出版社: Elsevier BV
作者: Bin Liu; Feng Gao; Hui Zhao; Shuai Yuan; Xingzhe Peng; Pengzhi Zhang; Jing Wang; Tongmei Zhang; Maosheng Duan; Yongqi Guo